IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
High-Dose Interferon Alfa in Treating Patients With Stage II or StageIII Melanoma
This study has been withdrawn prior to enrollment.
(There were no patient enrolled in this study at this site)
Sponsor:
Hackensack University Medical Center
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Hackensack University Medical Center
ClinicalTrials.gov Identifier:
NCT00447356
First received: March 12, 2007
Last updated: May 9, 2013
Last verified: May 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
| Study Status: | This study has been withdrawn prior to enrollment. |
|---|---|
| Study Completion Date: | No date given |
| Primary Completion Date: | No date given |